Diluted EPS came in at $-0.09 (+10.0% YoY), beat the $-0.10 consensus by $0.01.
Trailing eight quarters through Q2 2025
Common questions about Anixa Biosciences's Q2 2025 earnings report.
Anixa Biosciences (ANIX) reported Q2 2025 earnings on May 28, 2025 before market open.
Anixa Biosciences reported diluted EPS of $-0.09 for Q2 2025.
EPS beat the consensus estimate of $-0.10 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 10.0% from $-0.10.
You can read the 10-Q periodic report (0001641172-25-012701) directly on SEC EDGAR. The filing index links above go to sec.gov.